Donald Trump associate and noted health nut Robert F. Kennedy Jr. still has federal health regulators in his crosshairs. On ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the ...
"It is the FDA's role to ensure that drugs are safe and effective," said Dr. Patrizia Cavazzoni, director of the FDA's Center ...
The agency authorized Novavax to start a Phase 3 trial of its combination shot after the company “satisfactorily” addressed ...
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Credit: NDAB Creativity via Shutterstock. Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback